世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033146

ジェネリック医薬品市場の概要、競合分析、および予測(2017‐2026年)

MarketLine

Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

発刊日 2022/08/20

言語英語

体裁PDF/281ページ

ライセンス/価格281ページ

0000033146

Single
Site
Enterprisewide (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界のジェネリック医薬品業界プロファイルは、市場シェア、市場規模(2017年から2021年の価値および2026年までの予測)を含むトップラインの定性的および定量的な概要情報を提供します。また、主要な財務指標や市場内の競争圧力の分析など、主要企業に関する情報も含まれています。

主要なハイライト

  • このプロフィールでは、ジェネリック医薬品を、かつて特許で保護され、現在は失効している医療用医薬品のコピーと定義しています。ノーブランドのジェネリック医薬品とすべてのブランドのジェネリック医薬品の両方が含まれます。ただし、特許切れの医薬品で、元のメーカーが元の名称で提供し続けており、「ジェネリック医薬品適格」市場の一部を形成しているものは含まれません。
  • 市場価格は工場出荷時の価格で評価されています。
  • ここでいう市場規模とは、国・地域の医療用医薬品市場全体のうち、ジェネリック医薬品が占める割合のことです。したがって、市場規模の絶対値ではなく、ジェネリック医薬品の普及率の指標となります。
  • 地域別の数量は、数量データが存在する当該地域を構成する国の加重平均で計算されています。
  • なお、MarketLine社では、ジェネリック医薬品がどの国・地域でも医薬品市場の100%を占めるとは考えていないため、「1」または「100%」の数量は四捨五入によるものであることに注意してください。
  • すべての市場データおよび予測は名目で表示されており(すなわち、インフレ調整なし)、本レポートの作成に用いられたすべての通貨換算は、2021年の恒常為替レート(年間平均)を用いて計算されています。
  • 世界のジェネリック医薬品市場の2021年の総収益は3,214億ドルで、2016年から2021年の複合年間成長率(CAGR)は4.7%でした。
  • 市場の消費量は2016年から2021年にかけてCAGR1.9%で増加し、2021年には合計47.0%に達しました。
  • 過去5年間で、世界のジェネリック医薬品市場は5.2%の成長を記録しました。成長の原動力は主に人口動態の変化です。

調査範囲

  • 世界のジェネリック医薬品市場の規模、成長、主要セグメント、主要プレーヤーを特定することで、初歩的な調査にかかる時間を短縮できます。
  • ファイブフォース分析により、世界のジェネリック医薬品市場の競争力、魅力度を判断できます。
  • 大手企業のプロファイルは、主要なジェネリック医薬品市場における世界のプレーヤーのグローバルな事業と財務実績の詳細を明らかにします。
  • 5年間の予測で世界のジェネリック医薬品市場の将来の成長見通しを理解することにより、プレゼンテーションと売り込みに重みを加えることができます。

レポート詳細

目次

Table of Contents

1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive Landscape

2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions

3 Global Generics
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Generics in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Macroeconomic Indicators
7.1. Country data

8 Generics in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis

9 Macroeconomic Indicators
9.1. Country data

10 Generics in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis

11 Macroeconomic Indicators
11.1. Country data

12 Generics in Italy
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis

13 Macroeconomic Indicators
13.1. Country data

14 Generics in Japan
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis

15 Macroeconomic Indicators
15.1. Country data

16 Generics in Australia
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis

17 Macroeconomic Indicators
17.1. Country data

18 Generics in Canada
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis

19 Macroeconomic Indicators
19.1. Country data

20 Generics in China
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis

21 Macroeconomic Indicators
21.1. Country data

22 Generics in The Netherlands
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis

23 Macroeconomic Indicators
23.1. Country data

24 Generics in Spain
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis

25 Macroeconomic Indicators
25.1. Country data

26 Generics in The United Kingdom
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis

27 Macroeconomic Indicators
27.1. Country data

28 Generics in The United States
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis

29 Macroeconomic Indicators
29.1. Country data

30 Company Profiles

31 Appendix
31.1. Methodology
31.2. About MarketLine

Table of Contents

1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive Landscape

2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions

3 Global Generics
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Generics in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Macroeconomic Indicators
7.1. Country data

8 Generics in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis

9 Macroeconomic Indicators
9.1. Country data

10 Generics in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis

11 Macroeconomic Indicators
11.1. Country data

12 Generics in Italy
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis

13 Macroeconomic Indicators
13.1. Country data

14 Generics in Japan
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis

15 Macroeconomic Indicators
15.1. Country data

16 Generics in Australia
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis

17 Macroeconomic Indicators
17.1. Country data

18 Generics in Canada
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis

19 Macroeconomic Indicators
19.1. Country data

20 Generics in China
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis

21 Macroeconomic Indicators
21.1. Country data

22 Generics in The Netherlands
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis

23 Macroeconomic Indicators
23.1. Country data

24 Generics in Spain
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis

25 Macroeconomic Indicators
25.1. Country data

26 Generics in The United Kingdom
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis

27 Macroeconomic Indicators
27.1. Country data

28 Generics in The United States
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis

29 Macroeconomic Indicators
29.1. Country data

30 Company Profiles

31 Appendix
31.1. Methodology
31.2. About MarketLine

List of Tables
Table 1: Global generics market value: $ billion, 2016-21
Table 2: Global generics market volume: %, 2016-21
Table 3: Global generics market geography segmentation: $ billion, 2021
Table 4: Global generics market value forecast: $ billion, 2021-26
Table 5: Global generics market volume forecast: %, 2021-26
Table 6: Global size of population (million), 2017-21
Table 7: Global gdp (constant 2005 prices, $ billion), 2017-21
Table 8: Global gdp (current prices, $ billion), 2017-21
Table 9: Global inflation, 2017-21
Table 10: Global consumer price index (absolute), 2017-21
Table 11: Global exchange rate, 2017-21
Table 12: Asia-Pacific generics market value: $ billion, 2016-21
Table 13: Asia-Pacific generics market volume: %, 2016-21
Table 14: Asia-Pacific generics market geography segmentation: $ billion, 2021
Table 15: Asia-Pacific generics market value forecast: $ billion, 2021-26
Table 16: Asia-Pacific generics market volume forecast: %, 2021-26
Table 17: Europe generics market value: $ billion, 2016-21
Table 18: Europe generics market volume: %, 2016-21
Table 19: Europe generics market geography segmentation: $ billion, 2021
Table 20: Europe generics market value forecast: $ billion, 2021-26
Table 21: Europe generics market volume forecast: %, 2021-26
Table 22: Europe size of population (million), 2017-21
Table 23: Europe gdp (constant 2005 prices, $ billion), 2017-21
Table 24: Europe gdp (current prices, $ billion), 2017-21
Table 25: Europe inflation, 2017-21
Table 26: Europe consumer price index (absolute), 2017-21
Table 27: Europe exchange rate, 2017-21
Table 28: France generics market value: $ million, 2016-21
Table 29: France generics market volume: %, 2016-21
Table 30: France generics market geography segmentation: $ million, 2021
Table 31: France generics market value forecast: $ million, 2021-26
Table 32: France generics market volume forecast: %, 2021-26
Table 33: France size of population (million), 2017-21
Table 34: France gdp (constant 2005 prices, $ billion), 2017-21
Table 35: France gdp (current prices, $ billion), 2017-21
Table 36: France inflation, 2017-21
Table 37: France consumer price index (absolute), 2017-21
Table 38: France exchange rate, 2017-21
Table 39: Germany generics market value: $ billion, 2016-21
Table 40: Germany generics market volume: %, 2016-21
Table 41: Germany generics market geography segmentation: $ billion, 2021
Table 42: Germany generics market value forecast: $ billion, 2021-26
Table 43: Germany generics market volume forecast: %, 2021-26
Table 44: Germany size of population (million), 2017-21
Table 45: Germany gdp (constant 2005 prices, $ billion), 2017-21
Table 46: Germany gdp (current prices, $ billion), 2017-21
Table 47: Germany inflation, 2017-21
Table 48: Germany consumer price index (absolute), 2017-21
Table 49: Germany exchange rate, 2017-21
Table 50: Italy generics market value: $ million, 2016-21
Table 51: Italy generics market volume: %, 2016-21
Table 52: Italy generics market geography segmentation: $ million, 2021
Table 53: Italy generics market value forecast: $ million, 2021-26
Table 54: Italy generics market volume forecast: %, 2021-26
Table 55: Italy size of population (million), 2017-21
Table 56: Italy gdp (constant 2005 prices, $ billion), 2017-21
Table 57: Italy gdp (current prices, $ billion), 2017-21
Table 58: Italy inflation, 2017-21
Table 59: Italy consumer price index (absolute), 2017-21
Table 60: Italy exchange rate, 2017-21
Table 61: Japan generics market value: $ billion, 2016-21
Table 62: Japan generics market volume: %, 2016-21
Table 63: Japan generics market geography segmentation: $ billion, 2021
Table 64: Japan generics market value forecast: $ billion, 2021-26
Table 65: Japan generics market volume forecast: %, 2021-26
Table 66: Japan size of population (million), 2017-21
Table 67: Japan gdp (constant 2005 prices, $ billion), 2017-21
Table 68: Japan gdp (current prices, $ billion), 2017-21
Table 69: Japan inflation, 2017-21
Table 70: Japan consumer price index (absolute), 2017-21
Table 71: Japan exchange rate, 2017-21
Table 72: Australia generics market value: $ million, 2016-21
Table 73: Australia generics market volume: %, 2016-21
Table 74: Australia generics market geography segmentation: $ million, 2021
Table 75: Australia generics market value forecast: $ million, 2021-26
Table 76: Australia generics market volume forecast: %, 2021-26
Table 77: Australia size of population (million), 2017-21
Table 78: Australia gdp (constant 2005 prices, $ billion), 2017-21
Table 79: Australia gdp (current prices, $ billion), 2017-21
Table 80: Australia inflation, 2017-21

List of Figures
Figure 1: Global generics market value: $ billion, 2016-21
Figure 2: Global generics market volume: %, 2016-21
Figure 3: Global generics market geography segmentation: % share, by value, 2021
Figure 4: Global generics market value forecast: $ billion, 2021-26
Figure 5: Global generics market volume forecast: %, 2021-26
Figure 6: Forces driving competition in the global generics market, 2021
Figure 7: Drivers of buyer power in the global generics market, 2021
Figure 8: Drivers of supplier power in the global generics market, 2021
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2021
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2021
Figure 11: Drivers of degree of rivalry in the global generics market, 2021
Figure 12: Asia-Pacific generics market value: $ billion, 2016-21
Figure 13: Asia-Pacific generics market volume: %, 2016-21
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2021
Figure 15: Asia-Pacific generics market value forecast: $ billion, 2021-26
Figure 16: Asia-Pacific generics market volume forecast: %, 2021-26
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2021
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2021
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2021
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2021
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2021
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2021
Figure 23: Europe generics market value: $ billion, 2016-21
Figure 24: Europe generics market volume: %, 2016-21
Figure 25: Europe generics market geography segmentation: % share, by value, 2021
Figure 26: Europe generics market value forecast: $ billion, 2021-26
Figure 27: Europe generics market volume forecast: %, 2021-26
Figure 28: Forces driving competition in the generics market in Europe, 2021
Figure 29: Drivers of buyer power in the generics market in Europe, 2021
Figure 30: Drivers of supplier power in the generics market in Europe, 2021
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2021
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2021
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2021
Figure 34: France generics market value: $ million, 2016-21
Figure 35: France generics market volume: %, 2016-21
Figure 36: France generics market geography segmentation: % share, by value, 2021
Figure 37: France generics market value forecast: $ million, 2021-26
Figure 38: France generics market volume forecast: %, 2021-26
Figure 39: Forces driving competition in the generics market in France, 2021
Figure 40: Drivers of buyer power in the generics market in France, 2021
Figure 41: Drivers of supplier power in the generics market in France, 2021
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2021
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2021
Figure 44: Drivers of degree of rivalry in the generics market in France, 2021
Figure 45: Germany generics market value: $ billion, 2016-21
Figure 46: Germany generics market volume: %, 2016-21
Figure 47: Germany generics market geography segmentation: % share, by value, 2021
Figure 48: Germany generics market value forecast: $ billion, 2021-26
Figure 49: Germany generics market volume forecast: %, 2021-26
Figure 50: Forces driving competition in the generics market in Germany, 2021
Figure 51: Drivers of buyer power in the generics market in Germany, 2021
Figure 52: Drivers of supplier power in the generics market in Germany, 2021
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2021
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2021
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2021
Figure 56: Italy generics market value: $ million, 2016-21
Figure 57: Italy generics market volume: %, 2016-21
Figure 58: Italy generics market geography segmentation: % share, by value, 2021
Figure 59: Italy generics market value forecast: $ million, 2021-26
Figure 60: Italy generics market volume forecast: %, 2021-26
Figure 61: Forces driving competition in the generics market in Italy, 2021
Figure 62: Drivers of buyer power in the generics market in Italy, 2021
Figure 63: Drivers of supplier power in the generics market in Italy, 2021
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Italy, 2021
Figure 65: Factors influencing the threat of substitutes in the generics market in Italy, 2021
Figure 66: Drivers of degree of rivalry in the generics market in Italy, 2021
Figure 67: Japan generics market value: $ billion, 2016-21
Figure 68: Japan generics market volume: %, 2016-21
Figure 69: Japan generics market geography segmentation: % share, by value, 2021
Figure 70: Japan generics market value forecast: $ billion, 2021-26
Figure 71: Japan generics market volume forecast: %, 2021-26
Figure 72: Forces driving competition in the generics market in Japan, 2021
Figure 73: Drivers of buyer power in the generics market in Japan, 2021
Figure 74: Drivers of supplier power in the generics market in Japan, 2021
Figure 75: Factors influencing the likelihood of new entrants in the generics market in Japan, 2021
Figure 76: Factors influencing the threat of substitutes in the generics market in Japan, 2021
Figure 77: Drivers of degree of rivalry in the generics market in Japan, 2021
Figure 78: Australia generics market value: $ million, 2016-21
Figure 79: Australia generics market volume: %, 2016-21
Figure 80: Australia generics market geography segmentation: % share, by value, 2021

この商品のレポートナンバー

0000033146

TOP